Literature DB >> 21783370

Synthesis, biological evaluation, and molecular modeling of cinnamic acyl sulfonamide derivatives as novel antitubulin agents.

Yin Luo1, Ke-Ming Qiu, Xiang Lu, Kai Liu, Jie Fu, Hai-Liang Zhu.   

Abstract

A series of novel cinnamic acyl sulfonamide derivatives (9a-16e) have been designed and synthesized and their biological activities were also evaluated as potential tubulin polymerization inhibitors. Among all the compounds, 10c showed the most potent growth inhibitory activity against B16-F10 cancer cell line in vitro, with an IC(50) value of 0.8μg/mL. Docking simulation was performed to insert compound 10c into the crystal structure of tubulin at colchicine binding site to determine the probable binding model. Based on the preliminary results, compound 10c with potent inhibitory activity in tumor growth may be a potential anticancer agent.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21783370     DOI: 10.1016/j.bmc.2011.06.088

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

1.  Design, synthesis and biological evaluation of arylcinnamide hybrid derivatives as novel anticancer agents.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Mariem Chayah; M Encarnacion Camacho; Filippo Prencipe; Ernest Hamel; Francesca Consolaro; Giuseppe Basso; Giampietro Viola
Journal:  Eur J Med Chem       Date:  2014-05-10       Impact factor: 6.514

2.  Synthesis and evaluation of antiproliferative activity of substituted N-(9-oxo-9H-xanthen-4-yl)benzenesulfonamides.

Authors:  Somayeh Motavallizadeh; Asal Fallah-Tafti; Saeedeh Maleki; Amir Nasrolahi Shirazi; Mahboobeh Pordeli; Maliheh Safavi; Sussan Kabudanian Ardestani; Shaaban Asd; Rakesh Tiwari; Donghoon Oh; Abbas Shafiee; Alireza Foroumadi; Keykavous Parang; Tahmineh Akbarzadeh
Journal:  Tetrahedron Lett       Date:  2014-01-08       Impact factor: 2.415

Review 3.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

4.  Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors.

Authors:  Sultan Nacak Baytas; Nazan Inceler; Akin Yilmaz; Abdurrahman Olgac; Sevda Menevse; Erden Banoglu; Ernest Hamel; Roberta Bortolozzi; Giampietro Viola
Journal:  Bioorg Med Chem       Date:  2014-04-20       Impact factor: 3.641

5.  Synthesis and biological evaluation of novel 5-chloro-N-(4-sulfamoylbenzyl) salicylamide derivatives as tubulin polymerization inhibitors.

Authors:  Alaaeldin M F Galal; Maha M Soltan; Esam R Ahmed; Atef G Hanna
Journal:  Medchemcomm       Date:  2018-07-26       Impact factor: 3.597

6.  Discovery and SARs of trans-3-aryl acrylic acids and their analogs as novel anti-tobacco mosaic virus (TMV) agents.

Authors:  Meng Wu; Ziwen Wang; Chuisong Meng; Kailiang Wang; Yanna Hu; Lizhong Wang; Qingmin Wang
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

7.  Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.

Authors:  Mohamed Alswah; Ashraf H Bayoumi; Kamal Elgamal; Ahmed Elmorsy; Saleh Ihmaid; Hany E A Ahmed
Journal:  Molecules       Date:  2017-12-27       Impact factor: 4.411

8.  Genotoxic, Cytotoxic, Antigenotoxic, and Anticytotoxic Effects of Sulfonamide Chalcone Using the Ames Test and the Mouse Bone Marrow Micronucleus Test.

Authors:  Carolina Ribeiro E Silva; Flávio Fernandes Veloso Borges; Aline Bernardes; Caridad Noda Perez; Daniela de Melo E Silva; Lee Chen-Chen
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

9.  Antitumour, acute toxicity and molecular modeling studies of 4-(pyridin-4-yl)-6-(thiophen-2-yl) pyrimidin-2(1H)-one against Ehrlich ascites carcinoma and sarcoma-180.

Authors:  Dinesh Kumar; Pooja Sharma; Kunal Nepali; Girish Mahajan; Mubashir J Mintoo; Amarinder Singh; Gurpreet Singh; Dilip M Mondhe; Gurdarshan Singh; Subheet K Jain; Girish K Gupta; Fidele Ntie-Kang
Journal:  Heliyon       Date:  2018-06-27

10.  Synthesis, Molecular Structure, Metabolic Stability and QSAR Studies of a Novel Series of Anticancer N-Acylbenzenesulfonamides.

Authors:  Beata Żołnowska; Jarosław Sławiński; Mariusz Belka; Tomasz Bączek; Anna Kawiak; Jarosław Chojnacki; Aneta Pogorzelska; Krzysztof Szafrański
Journal:  Molecules       Date:  2015-10-21       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.